These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. Drug treatments of levodopa-induced dyskinesias. Vale S Lancet; 1999 Aug; 354(9177):511. PubMed ID: 10465195 [No Abstract] [Full Text] [Related]
68. Rationale for current therapies in Parkinson's disease. Romrell J; Fernandez HH; Okun MS Expert Opin Pharmacother; 2003 Oct; 4(10):1747-61. PubMed ID: 14521485 [TBL] [Abstract][Full Text] [Related]
69. Parkinson's disease therapy: tailoring choices for early and late disease, young and old patients. Jankovic J Clin Neuropharmacol; 2000; 23(5):252-61. PubMed ID: 11154092 [TBL] [Abstract][Full Text] [Related]
70. Medical treatment of Parkinson disease. Stacy M Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824 [TBL] [Abstract][Full Text] [Related]
72. [A comparative study of efficacy of dopamine receptors agonists and catechol-O-methyltransferase in the treatment of late stages of Parkinson's disease]. Krivonos OV; Fedorova NV; Chigir' IP Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):24-30. PubMed ID: 14870689 [TBL] [Abstract][Full Text] [Related]
73. The comparative effects of medical therapies for Parkinson's disease. Horn S; Stern MB Neurology; 2004 Oct; 63(7 Suppl 2):S7-12. PubMed ID: 15477585 [No Abstract] [Full Text] [Related]
74. [Treatment of Parkinson disease]. Cardoso F Arq Neuropsiquiatr; 1995 Mar; 53(1):1-10. PubMed ID: 7575192 [TBL] [Abstract][Full Text] [Related]
75. Nitecapone and selegiline as effective adjuncts to L-DOPA in reserpine-induced catatonia in mice. Singh A; Kulkarni SK Methods Find Exp Clin Pharmacol; 2002; 24(1):23-9. PubMed ID: 11980384 [TBL] [Abstract][Full Text] [Related]
78. Validation of a rodent model of Parkinson's Disease: evidence of a therapeutic window for oral Sinemet. Lindner MD; Plone MA; Francis JM; Emerich DF Brain Res Bull; 1996; 39(6):367-72. PubMed ID: 9138746 [TBL] [Abstract][Full Text] [Related]
79. [The usefulness of dopaminergic drugs in traumatic brain injury]. Orient-López F; Terre- Boliart R; Bernabeu-Guitart M; Ramón-Rona S; Pérez-Miras A Rev Neurol; 2002 Aug 16-31; 35(4):362-6. PubMed ID: 12235569 [TBL] [Abstract][Full Text] [Related]
80. Parkinson disease: managing a complex, progressive disease at all stages. Giroux ML Cleve Clin J Med; 2007 May; 74(5):313-4, 317-8, 320-2 passim. PubMed ID: 17506237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]